Scientific Publications by FDA Staff
J Biomed Mater Res B Appl Biomater 2013 Oct;101(7):1191-9
Impact of copolymer ratio on drug distribution in styrene-isobutylene-styrene block copolymers.
McDermott MK, Kim CS, Saylor DM, Patwardhan DV
Drug-polymer composite coatings, composed of styrene-isobutylene-styrene (SIBS) tri-block copolymers, are frequently used in controlled drug release biomedical device applications. In this work, we used atomic force microscopy to characterize the effects of different drug loadings and polymer chemistries (i.e., block copolymer ratio) on the variation of surface structures and compositions of SIBS-tetracycline (SIBS-TC) cast composites including tetracycline (TC) drug amount, drug phase size distribution, and drug and polymer phase morphologies. We tested the structural variations by fabricating and characterizing two types of composite specimens, that is, SIBS15 and SIBS30, composed of 15 and 30 Wt % of polystyrene (PS), respectively. The differences in the distribution of TC drug, PS, and polyisobutylene (PIB) polymer phase structures observed in SIBS15 and SIBS30 resulted in more drug at the surface of SIBS30 compared to SIBS15. To support the experimental findings, we have determined the Hildebrand solubility parameter of TC using molecular dynamics (MD) computation and compared it to the polymer components, PS and PIB. The MD results show that the solubility parameter of TC is much closer to that of PS than PIB, which demonstrates a higher thermodynamic stability of TC-PS mixtures.
|Category: Journal Article|
|PubMed ID: #23564439||DOI: 10.1002/jbm.b.32930|
|Includes FDA Authors from Scientific Area(s): Medical Devices|
|Entry Created: 2013-04-09||Entry Last Modified: 2016-03-21|